$0.070
(0%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 10:11am | ||||
RHINOMED LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (13-Nov) $11,471,000 (1,037th) |
Close (30-Jun) $0.070 |
Volume (30-Jun) 0 |
Shortsold (8-Jan) 4,400 (0.00%) (473rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.04 |
CEO presentation to 2021 AGM
RNO released this announcement to the ASX on 19 November 2021, 9:51. The announcement is not marked as price sensitive, and is 26 page(s) in length and 1.17MB in size.
You can view all announcements from RNO and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RNO | |
|---|---|
| Change in substantial holding WG | 18 May 2023, 9:23 |
| App 3Y MJ | 4 May 2023, 10:56 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 9:19 |
| CEO presentation to 2021 AGM | 19 November 2021, 9:51 |
| Chairman's Address to Shareholders 2021 AGM | 19 November 2021, 9:31 |
| Investor update November 2021 | 11 November 2021, 9:24 |
| Jobkeeper Payments Notice | 3 November 2021, 14:58 |
If you were already registered, log in here.
If you were already registered, log in here.